| 20th Sep 2022 7:00 am |
RNS |
Interim results for the six-months to 30 June 2022 |
| 12th Sep 2022 1:00 pm |
RNS |
Change of Interim Results Date |
| 5th Sep 2022 7:00 am |
RNS |
Notice of results |
| 1st Sep 2022 7:00 am |
RNS |
Notice of AGM |
| 30th Aug 2022 7:00 am |
RNS |
Additional $8.2M of Funding from BARDA |
| 19th Aug 2022 9:13 am |
RNS |
Grant of Options |
| 7th Jul 2022 7:00 am |
RNS |
Stockholder waiver granted |
| 23rd Jun 2022 7:00 am |
RNS |
Removal of Regulation S restrictions |
| 17th Jun 2022 10:40 am |
RNS |
Mediscience Award Win |
| 13th Jun 2022 7:00 am |
RNS |
Initiation of DFU Validation Study |
| 10th May 2022 7:00 am |
RNS |
Publication of Annual Financial Report |
| 13th Apr 2022 7:00 am |
RNS |
Appointment: V.P of Marketing |
| 21st Mar 2022 7:00 am |
RNS |
Final Results |
| 9th Mar 2022 7:00 am |
RNS |
Notice of Full Year Results |
| 4th Feb 2022 7:00 am |
RNS |
Grant of share options and cash bonus |
| 1st Feb 2022 7:00 am |
RNS |
Trading Update and Notice of Results |
| 11th Jan 2022 7:00 am |
RNS |
Director/PDMR Shareholding |
| 23rd Dec 2021 3:13 pm |
RNS |
Share Dealing and Exercise of Options |
| 21st Dec 2021 7:00 am |
RNS |
Grant of share options and Management update |
| 1st Dec 2021 7:00 am |
RNS |
Appointment of CFO |
| 18th Nov 2021 7:00 am |
RNS |
Enrolment Completed for DFU Training Study |
| 16th Nov 2021 7:00 am |
RNS |
Clinical results presented at US Burn Conference |
| 20th Oct 2021 7:00 am |
RNS |
Appointment of Joint Broker |
| 11th Oct 2021 2:00 pm |
RNS |
Grant of share options |
| 13th Sep 2021 7:00 am |
RNS |
Half-year Report |
| 7th Sep 2021 7:00 am |
RNS |
Notice of Results |
| 9th Aug 2021 7:00 am |
RNS |
Kick-off event to launch clinical study |
| 15th Jul 2021 7:00 am |
RNS |
Holding(s) in Company |
| 24th Jun 2021 7:00 am |
RNS |
Contract Award from US Department of Defense |
| 22nd Jun 2021 7:00 am |
RNS |
Admission to trading on AIM; First Day of Dealings |
